Advertisement

Index by author

March 01, 1995; Volume 47,Issue 3

A

  1. Abiteboul, M

    1. Stereoselective esterase activity of human serum albumin toward ketoprofen glucuronide.
      N Dubois-Presle, F Lapicque, M H Maurice, S Fournel-Gigleux, J Magdalou, M Abiteboul, G Siest and P Netter
      Molecular Pharmacology March 1995, 47 (3) 647-653;

  2. Amin, J

    1. Zinc is a mixed antagonist of homomeric rho 1 gamma-aminobutyric acid-activated channels.
      Y Chang, J Amin and D S Weiss
      Molecular Pharmacology March 1995, 47 (3) 595-602;

  3. Antonov, S M

    1. Novel adamantane derivatives act as blockers of open ligand-gated channels and as anticonvulsants.
      S M Antonov, J W Johnson, N Y Lukomskaya, N N Potapyeva, V E Gmiro and L G Magazanik
      Molecular Pharmacology March 1995, 47 (3) 558-567;

B

  1. Bacchi, A

    1. Polymorphism-structure relationships of rifamexil, an antibiotic rifamycin derivative.
      A Bacchi, G Mori, G Pelizzi, G Pelosi, M Nebuloni and G B Panzone
      Molecular Pharmacology March 1995, 47 (3) 611-623;

  2. Bacsi, S G

    1. Orientation of the heterodimeric aryl hydrocarbon (dioxin) receptor complex on its asymmetric DNA recognition sequence.
      S G Bacsi, S Reisz-Porszasz and O Hankinson
      Molecular Pharmacology March 1995, 47 (3) 432-438;

  3. Bao, Y

    1. Biodistribution and metabolism of internally 3H-labeled oligonucleotides. II. 3',5'-blocked oligonucleotides.
      H Sands, L J Gorey-Feret, S P Ho, Y Bao, A J Cocuzza, D Chidester and F W Hobbs
      Molecular Pharmacology March 1995, 47 (3) 636-646;

  4. Barouki, R

    1. Insulin down-regulates cytochrome P450 2B and 2E expression at the post-transcriptional level in the rat hepatoma cell line.
      I De Waziers, M Garlatti, J Bouguet, P H Beaune and R Barouki
      Molecular Pharmacology March 1995, 47 (3) 474-479;

  5. Beaune, P H

    1. Insulin down-regulates cytochrome P450 2B and 2E expression at the post-transcriptional level in the rat hepatoma cell line.
      I De Waziers, M Garlatti, J Bouguet, P H Beaune and R Barouki
      Molecular Pharmacology March 1995, 47 (3) 474-479;

  6. Berger, T S

    1. Nonsteroidal human progesterone receptor modulators from the marine alga Cymopolia barbata.
      C Pathirana, R B Stein, T S Berger, W Fenical, T Ianiro, D E Mais, A Torres and M E Goldman
      Molecular Pharmacology March 1995, 47 (3) 630-635;

  7. Bloom, J W

    1. Regulation of airway muscarinic cholinergic receptor subtypes by chronic anticholinergic treatment.
      P A Witt-Enderby, H I Yamamura, M Halonen, J Lai, J D Palmer and J W Bloom
      Molecular Pharmacology March 1995, 47 (3) 485-490;

  8. Bouguet, J

    1. Insulin down-regulates cytochrome P450 2B and 2E expression at the post-transcriptional level in the rat hepatoma cell line.
      I De Waziers, M Garlatti, J Bouguet, P H Beaune and R Barouki
      Molecular Pharmacology March 1995, 47 (3) 474-479;

  9. Brachet-Cota, A L

    1. Sodium-retaining activity of some natural and synthetic 21-deoxysteroids.
      G Burton, M Galigniana, S De Lavallaz, A L Brachet-Cota, E M Sproviero, A A Ghini, C P Lantos and M C Damasco
      Molecular Pharmacology March 1995, 47 (3) 535-543;

  10. Burgess, G M

    1. Signal transduction pathways for B1 and B2 bradykinin receptors in bovine pulmonary artery endothelial cells.
      J A Smith, C Webb, J Holford and G M Burgess
      Molecular Pharmacology March 1995, 47 (3) 525-534;

  11. Burton, G

    1. Sodium-retaining activity of some natural and synthetic 21-deoxysteroids.
      G Burton, M Galigniana, S De Lavallaz, A L Brachet-Cota, E M Sproviero, A A Ghini, C P Lantos and M C Damasco
      Molecular Pharmacology March 1995, 47 (3) 535-543;

C

  1. Chang, Y

    1. Zinc is a mixed antagonist of homomeric rho 1 gamma-aminobutyric acid-activated channels.
      Y Chang, J Amin and D S Weiss
      Molecular Pharmacology March 1995, 47 (3) 595-602;

  2. Chavkin, C

    1. Kappa-opioid receptors couple to inwardly rectifying potassium channels when coexpressed by Xenopus oocytes.
      D J Henry, D K Grandy, H A Lester, N Davidson and C Chavkin
      Molecular Pharmacology March 1995, 47 (3) 551-557;

  3. Chidester, D

    1. Biodistribution and metabolism of internally 3H-labeled oligonucleotides. II. 3',5'-blocked oligonucleotides.
      H Sands, L J Gorey-Feret, S P Ho, Y Bao, A J Cocuzza, D Chidester and F W Hobbs
      Molecular Pharmacology March 1995, 47 (3) 636-646;

  4. Choudhary, M S

    1. Differential ergoline and ergopeptine binding to 5-hydroxytryptamine2A receptors: ergolines require an aromatic residue at position 340 for high affinity binding.
      M S Choudhary, N Sachs, A Uluer, R A Glennon, R B Westkaemper and B L Roth
      Molecular Pharmacology March 1995, 47 (3) 450-457;

  5. Clementi, E

    1. Nitric oxide modulation of agonist-evoked intracellular Ca2+ release in neurosecretory PC-12 cells: inhibition of phospholipase C activity via cyclic GMP-dependent protein kinase I.
      E Clementi, I Vecchio, C Sciorati and G Nisticò
      Molecular Pharmacology March 1995, 47 (3) 517-524;

  6. Cocuzza, A J

    1. Biodistribution and metabolism of internally 3H-labeled oligonucleotides. II. 3',5'-blocked oligonucleotides.
      H Sands, L J Gorey-Feret, S P Ho, Y Bao, A J Cocuzza, D Chidester and F W Hobbs
      Molecular Pharmacology March 1995, 47 (3) 636-646;

D

  1. Damasco, M C

    1. Sodium-retaining activity of some natural and synthetic 21-deoxysteroids.
      G Burton, M Galigniana, S De Lavallaz, A L Brachet-Cota, E M Sproviero, A A Ghini, C P Lantos and M C Damasco
      Molecular Pharmacology March 1995, 47 (3) 535-543;

  2. Davidson, N

    1. Kappa-opioid receptors couple to inwardly rectifying potassium channels when coexpressed by Xenopus oocytes.
      D J Henry, D K Grandy, H A Lester, N Davidson and C Chavkin
      Molecular Pharmacology March 1995, 47 (3) 551-557;

  3. De Lavallaz, S

    1. Sodium-retaining activity of some natural and synthetic 21-deoxysteroids.
      G Burton, M Galigniana, S De Lavallaz, A L Brachet-Cota, E M Sproviero, A A Ghini, C P Lantos and M C Damasco
      Molecular Pharmacology March 1995, 47 (3) 535-543;

  4. De Waziers, I

    1. Insulin down-regulates cytochrome P450 2B and 2E expression at the post-transcriptional level in the rat hepatoma cell line.
      I De Waziers, M Garlatti, J Bouguet, P H Beaune and R Barouki
      Molecular Pharmacology March 1995, 47 (3) 474-479;

  5. Dubois-Presle, N

    1. Stereoselective esterase activity of human serum albumin toward ketoprofen glucuronide.
      N Dubois-Presle, F Lapicque, M H Maurice, S Fournel-Gigleux, J Magdalou, M Abiteboul, G Siest and P Netter
      Molecular Pharmacology March 1995, 47 (3) 647-653;

F

  1. Fan, P

    1. Nonopioid mechanism of morphine modulation of the activation of 5-hydroxytryptamine type 3 receptors.
      P Fan
      Molecular Pharmacology March 1995, 47 (3) 491-495;

  2. Fenical, W

    1. Nonsteroidal human progesterone receptor modulators from the marine alga Cymopolia barbata.
      C Pathirana, R B Stein, T S Berger, W Fenical, T Ianiro, D E Mais, A Torres and M E Goldman
      Molecular Pharmacology March 1995, 47 (3) 630-635;

  3. Fournel-Gigleux, S

    1. Stereoselective esterase activity of human serum albumin toward ketoprofen glucuronide.
      N Dubois-Presle, F Lapicque, M H Maurice, S Fournel-Gigleux, J Magdalou, M Abiteboul, G Siest and P Netter
      Molecular Pharmacology March 1995, 47 (3) 647-653;

G

  1. Galigniana, M

    1. Sodium-retaining activity of some natural and synthetic 21-deoxysteroids.
      G Burton, M Galigniana, S De Lavallaz, A L Brachet-Cota, E M Sproviero, A A Ghini, C P Lantos and M C Damasco
      Molecular Pharmacology March 1995, 47 (3) 535-543;

  2. Garlatti, M

    1. Insulin down-regulates cytochrome P450 2B and 2E expression at the post-transcriptional level in the rat hepatoma cell line.
      I De Waziers, M Garlatti, J Bouguet, P H Beaune and R Barouki
      Molecular Pharmacology March 1995, 47 (3) 474-479;

  3. Gershengorn, M C

    1. Distinct roles for arginines in transmembrane helices 6 and 7 of the thyrotropin-releasing hormone receptor.
      J H Perlman, L Laakkonen, R Osman and M C Gershengorn
      Molecular Pharmacology March 1995, 47 (3) 480-484;

  4. Ghini, A A

    1. Sodium-retaining activity of some natural and synthetic 21-deoxysteroids.
      G Burton, M Galigniana, S De Lavallaz, A L Brachet-Cota, E M Sproviero, A A Ghini, C P Lantos and M C Damasco
      Molecular Pharmacology March 1995, 47 (3) 535-543;

  5. Glennon, R A

    1. Differential ergoline and ergopeptine binding to 5-hydroxytryptamine2A receptors: ergolines require an aromatic residue at position 340 for high affinity binding.
      M S Choudhary, N Sachs, A Uluer, R A Glennon, R B Westkaemper and B L Roth
      Molecular Pharmacology March 1995, 47 (3) 450-457;

  6. Gmiro, V E

    1. Novel adamantane derivatives act as blockers of open ligand-gated channels and as anticonvulsants.
      S M Antonov, J W Johnson, N Y Lukomskaya, N N Potapyeva, V E Gmiro and L G Magazanik
      Molecular Pharmacology March 1995, 47 (3) 558-567;

  7. Goldman, M E

    1. Nonsteroidal human progesterone receptor modulators from the marine alga Cymopolia barbata.
      C Pathirana, R B Stein, T S Berger, W Fenical, T Ianiro, D E Mais, A Torres and M E Goldman
      Molecular Pharmacology March 1995, 47 (3) 630-635;

  8. Gorey-Feret, L J

    1. Biodistribution and metabolism of internally 3H-labeled oligonucleotides. II. 3',5'-blocked oligonucleotides.
      H Sands, L J Gorey-Feret, S P Ho, Y Bao, A J Cocuzza, D Chidester and F W Hobbs
      Molecular Pharmacology March 1995, 47 (3) 636-646;

  9. Grandy, D K

    1. Kappa-opioid receptors couple to inwardly rectifying potassium channels when coexpressed by Xenopus oocytes.
      D J Henry, D K Grandy, H A Lester, N Davidson and C Chavkin
      Molecular Pharmacology March 1995, 47 (3) 551-557;

  10. Gu, H

    1. Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: amphetamine specificity for inhibition and efflux.
      S C Wall, H Gu and G Rudnick
      Molecular Pharmacology March 1995, 47 (3) 544-550;

  11. Guastella, J

    1. In vitro pharmacology of ACEA-1021 and ACEA-1031: systemically active quinoxalinediones with high affinity and selectivity for N-methyl-D-aspartate receptor glycine sites.
      R M Woodward, J E Huettner, J Guastella, J F Keana and E Weber
      Molecular Pharmacology March 1995, 47 (3) 568-581;

  12. Guillemare, E

    1. Glibenclamide opens ATP-sensitive potassium channels in Xenopus oocyte follicular cells during metabolic stress.
      E Guillemare, M Lazdunski and E Honoré
      Molecular Pharmacology March 1995, 47 (3) 588-594;

H

  1. Halonen, M

    1. Regulation of airway muscarinic cholinergic receptor subtypes by chronic anticholinergic treatment.
      P A Witt-Enderby, H I Yamamura, M Halonen, J Lai, J D Palmer and J W Bloom
      Molecular Pharmacology March 1995, 47 (3) 485-490;

  2. Hankinson, O

    1. Orientation of the heterodimeric aryl hydrocarbon (dioxin) receptor complex on its asymmetric DNA recognition sequence.
      S G Bacsi, S Reisz-Porszasz and O Hankinson
      Molecular Pharmacology March 1995, 47 (3) 432-438;

  3. Henry, D J

    1. Kappa-opioid receptors couple to inwardly rectifying potassium channels when coexpressed by Xenopus oocytes.
      D J Henry, D K Grandy, H A Lester, N Davidson and C Chavkin
      Molecular Pharmacology March 1995, 47 (3) 551-557;

  4. Hjorth, S A

    1. Interaction between the nonpeptide angiotensin antagonist SKF-108,566 and histidine 256 (HisVI:16) of the angiotensin type 1 receptor.
      H T Schambye, S A Hjorth, J Weinstock and T W Schwartz
      Molecular Pharmacology March 1995, 47 (3) 425-431;

  5. Ho, S P

    1. Biodistribution and metabolism of internally 3H-labeled oligonucleotides. II. 3',5'-blocked oligonucleotides.
      H Sands, L J Gorey-Feret, S P Ho, Y Bao, A J Cocuzza, D Chidester and F W Hobbs
      Molecular Pharmacology March 1995, 47 (3) 636-646;

  6. Hobbs, F W

    1. Biodistribution and metabolism of internally 3H-labeled oligonucleotides. II. 3',5'-blocked oligonucleotides.
      H Sands, L J Gorey-Feret, S P Ho, Y Bao, A J Cocuzza, D Chidester and F W Hobbs
      Molecular Pharmacology March 1995, 47 (3) 636-646;

  7. Holford, J

    1. Signal transduction pathways for B1 and B2 bradykinin receptors in bovine pulmonary artery endothelial cells.
      J A Smith, C Webb, J Holford and G M Burgess
      Molecular Pharmacology March 1995, 47 (3) 525-534;

  8. Honoré, E

    1. Glibenclamide opens ATP-sensitive potassium channels in Xenopus oocyte follicular cells during metabolic stress.
      E Guillemare, M Lazdunski and E Honoré
      Molecular Pharmacology March 1995, 47 (3) 588-594;

  9. Huettner, J E

    1. In vitro pharmacology of ACEA-1021 and ACEA-1031: systemically active quinoxalinediones with high affinity and selectivity for N-methyl-D-aspartate receptor glycine sites.
      R M Woodward, J E Huettner, J Guastella, J F Keana and E Weber
      Molecular Pharmacology March 1995, 47 (3) 568-581;
    2. Differential antagonism of alpha-amino-3-hydroxy-5-methyl-4- isoxazolepropionic acid-preferring and kainate-preferring receptors by 2,3-benzodiazepines.
      T J Wilding and J E Huettner
      Molecular Pharmacology March 1995, 47 (3) 582-587;

I

  1. Ianiro, T

    1. Nonsteroidal human progesterone receptor modulators from the marine alga Cymopolia barbata.
      C Pathirana, R B Stein, T S Berger, W Fenical, T Ianiro, D E Mais, A Torres and M E Goldman
      Molecular Pharmacology March 1995, 47 (3) 630-635;

J

  1. Johnson, J W

    1. Novel adamantane derivatives act as blockers of open ligand-gated channels and as anticonvulsants.
      S M Antonov, J W Johnson, N Y Lukomskaya, N N Potapyeva, V E Gmiro and L G Magazanik
      Molecular Pharmacology March 1995, 47 (3) 558-567;

K

  1. Keana, J F

    1. In vitro pharmacology of ACEA-1021 and ACEA-1031: systemically active quinoxalinediones with high affinity and selectivity for N-methyl-D-aspartate receptor glycine sites.
      R M Woodward, J E Huettner, J Guastella, J F Keana and E Weber
      Molecular Pharmacology March 1995, 47 (3) 568-581;

  2. Kellermann, O

    1. Functional serotonin-2B receptors are expressed by a teratocarcinoma-derived cell line during serotoninergic differentiation.
      S Loric, L Maroteaux, O Kellermann and J M Launay
      Molecular Pharmacology March 1995, 47 (3) 458-466;

  3. Klein, D C

    1. Norepinephrine stimulation of pineal cyclic AMP response element-binding protein phosphorylation: primary role of a beta-adrenergic receptor/cyclic AMP mechanism.
      P H Roseboom and D C Klein
      Molecular Pharmacology March 1995, 47 (3) 439-449;

  4. Komatsu, M

    1. Sodium fluoride stimulates exocytosis at a late site of calcium interaction in stimulus-secretion coupling: studies with the RINm5F beta cell line.
      M Komatsu, A M McDermott and G W Sharp
      Molecular Pharmacology March 1995, 47 (3) 496-508;

  5. Kong, Y

    1. Molecular cloning and expression of a human secretin receptor.
      D R Patel, Y Kong and S P Sreedharan
      Molecular Pharmacology March 1995, 47 (3) 467-473;

L

  1. Laakkonen, L

    1. Distinct roles for arginines in transmembrane helices 6 and 7 of the thyrotropin-releasing hormone receptor.
      J H Perlman, L Laakkonen, R Osman and M C Gershengorn
      Molecular Pharmacology March 1995, 47 (3) 480-484;

  2. Lai, J

    1. Regulation of airway muscarinic cholinergic receptor subtypes by chronic anticholinergic treatment.
      P A Witt-Enderby, H I Yamamura, M Halonen, J Lai, J D Palmer and J W Bloom
      Molecular Pharmacology March 1995, 47 (3) 485-490;

  3. Lantos, C P

    1. Sodium-retaining activity of some natural and synthetic 21-deoxysteroids.
      G Burton, M Galigniana, S De Lavallaz, A L Brachet-Cota, E M Sproviero, A A Ghini, C P Lantos and M C Damasco
      Molecular Pharmacology March 1995, 47 (3) 535-543;

  4. Lapicque, F

    1. Stereoselective esterase activity of human serum albumin toward ketoprofen glucuronide.
      N Dubois-Presle, F Lapicque, M H Maurice, S Fournel-Gigleux, J Magdalou, M Abiteboul, G Siest and P Netter
      Molecular Pharmacology March 1995, 47 (3) 647-653;

  5. Launay, J M

    1. Functional serotonin-2B receptors are expressed by a teratocarcinoma-derived cell line during serotoninergic differentiation.
      S Loric, L Maroteaux, O Kellermann and J M Launay
      Molecular Pharmacology March 1995, 47 (3) 458-466;

  6. Lazdunski, M

    1. Glibenclamide opens ATP-sensitive potassium channels in Xenopus oocyte follicular cells during metabolic stress.
      E Guillemare, M Lazdunski and E Honoré
      Molecular Pharmacology March 1995, 47 (3) 588-594;

  7. Lester, H A

    1. Kappa-opioid receptors couple to inwardly rectifying potassium channels when coexpressed by Xenopus oocytes.
      D J Henry, D K Grandy, H A Lester, N Davidson and C Chavkin
      Molecular Pharmacology March 1995, 47 (3) 551-557;

  8. Loric, S

    1. Functional serotonin-2B receptors are expressed by a teratocarcinoma-derived cell line during serotoninergic differentiation.
      S Loric, L Maroteaux, O Kellermann and J M Launay
      Molecular Pharmacology March 1995, 47 (3) 458-466;

  9. Lukomskaya, N Y

    1. Novel adamantane derivatives act as blockers of open ligand-gated channels and as anticonvulsants.
      S M Antonov, J W Johnson, N Y Lukomskaya, N N Potapyeva, V E Gmiro and L G Magazanik
      Molecular Pharmacology March 1995, 47 (3) 558-567;

M

  1. Magazanik, L G

    1. Novel adamantane derivatives act as blockers of open ligand-gated channels and as anticonvulsants.
      S M Antonov, J W Johnson, N Y Lukomskaya, N N Potapyeva, V E Gmiro and L G Magazanik
      Molecular Pharmacology March 1995, 47 (3) 558-567;

  2. Magdalou, J

    1. Stereoselective esterase activity of human serum albumin toward ketoprofen glucuronide.
      N Dubois-Presle, F Lapicque, M H Maurice, S Fournel-Gigleux, J Magdalou, M Abiteboul, G Siest and P Netter
      Molecular Pharmacology March 1995, 47 (3) 647-653;

  3. Mais, D E

    1. Nonsteroidal human progesterone receptor modulators from the marine alga Cymopolia barbata.
      C Pathirana, R B Stein, T S Berger, W Fenical, T Ianiro, D E Mais, A Torres and M E Goldman
      Molecular Pharmacology March 1995, 47 (3) 630-635;

  4. Maroteaux, L

    1. Functional serotonin-2B receptors are expressed by a teratocarcinoma-derived cell line during serotoninergic differentiation.
      S Loric, L Maroteaux, O Kellermann and J M Launay
      Molecular Pharmacology March 1995, 47 (3) 458-466;

  5. Maurice, M H

    1. Stereoselective esterase activity of human serum albumin toward ketoprofen glucuronide.
      N Dubois-Presle, F Lapicque, M H Maurice, S Fournel-Gigleux, J Magdalou, M Abiteboul, G Siest and P Netter
      Molecular Pharmacology March 1995, 47 (3) 647-653;

  6. McDermott, A M

    1. Sodium fluoride stimulates exocytosis at a late site of calcium interaction in stimulus-secretion coupling: studies with the RINm5F beta cell line.
      M Komatsu, A M McDermott and G W Sharp
      Molecular Pharmacology March 1995, 47 (3) 496-508;

  7. Mori, G

    1. Polymorphism-structure relationships of rifamexil, an antibiotic rifamycin derivative.
      A Bacchi, G Mori, G Pelizzi, G Pelosi, M Nebuloni and G B Panzone
      Molecular Pharmacology March 1995, 47 (3) 611-623;

N

  1. Nahorski, S R

    1. Heterologous desensitization of both phosphoinositide and Ca2+ signaling in SH-SY5Y neuroblastoma cells: a role for intracellular Ca2+ store depletion?
      G B Willars and S R Nahorski
      Molecular Pharmacology March 1995, 47 (3) 509-516;

  2. Nebuloni, M

    1. Polymorphism-structure relationships of rifamexil, an antibiotic rifamycin derivative.
      A Bacchi, G Mori, G Pelizzi, G Pelosi, M Nebuloni and G B Panzone
      Molecular Pharmacology March 1995, 47 (3) 611-623;

  3. Netter, P

    1. Stereoselective esterase activity of human serum albumin toward ketoprofen glucuronide.
      N Dubois-Presle, F Lapicque, M H Maurice, S Fournel-Gigleux, J Magdalou, M Abiteboul, G Siest and P Netter
      Molecular Pharmacology March 1995, 47 (3) 647-653;

  4. Nisticò, G

    1. Nitric oxide modulation of agonist-evoked intracellular Ca2+ release in neurosecretory PC-12 cells: inhibition of phospholipase C activity via cyclic GMP-dependent protein kinase I.
      E Clementi, I Vecchio, C Sciorati and G Nisticò
      Molecular Pharmacology March 1995, 47 (3) 517-524;

O

  1. Osman, R

    1. Distinct roles for arginines in transmembrane helices 6 and 7 of the thyrotropin-releasing hormone receptor.
      J H Perlman, L Laakkonen, R Osman and M C Gershengorn
      Molecular Pharmacology March 1995, 47 (3) 480-484;

P

  1. Palmer, J D

    1. Regulation of airway muscarinic cholinergic receptor subtypes by chronic anticholinergic treatment.
      P A Witt-Enderby, H I Yamamura, M Halonen, J Lai, J D Palmer and J W Bloom
      Molecular Pharmacology March 1995, 47 (3) 485-490;

  2. Panzone, G B

    1. Polymorphism-structure relationships of rifamexil, an antibiotic rifamycin derivative.
      A Bacchi, G Mori, G Pelizzi, G Pelosi, M Nebuloni and G B Panzone
      Molecular Pharmacology March 1995, 47 (3) 611-623;

  3. Patel, D R

    1. Molecular cloning and expression of a human secretin receptor.
      D R Patel, Y Kong and S P Sreedharan
      Molecular Pharmacology March 1995, 47 (3) 467-473;

  4. Pathirana, C

    1. Nonsteroidal human progesterone receptor modulators from the marine alga Cymopolia barbata.
      C Pathirana, R B Stein, T S Berger, W Fenical, T Ianiro, D E Mais, A Torres and M E Goldman
      Molecular Pharmacology March 1995, 47 (3) 630-635;

  5. Pelizzi, G

    1. Polymorphism-structure relationships of rifamexil, an antibiotic rifamycin derivative.
      A Bacchi, G Mori, G Pelizzi, G Pelosi, M Nebuloni and G B Panzone
      Molecular Pharmacology March 1995, 47 (3) 611-623;

  6. Pelosi, G

    1. Polymorphism-structure relationships of rifamexil, an antibiotic rifamycin derivative.
      A Bacchi, G Mori, G Pelizzi, G Pelosi, M Nebuloni and G B Panzone
      Molecular Pharmacology March 1995, 47 (3) 611-623;

  7. Perlman, J H

    1. Distinct roles for arginines in transmembrane helices 6 and 7 of the thyrotropin-releasing hormone receptor.
      J H Perlman, L Laakkonen, R Osman and M C Gershengorn
      Molecular Pharmacology March 1995, 47 (3) 480-484;

  8. Potapyeva, N N

    1. Novel adamantane derivatives act as blockers of open ligand-gated channels and as anticonvulsants.
      S M Antonov, J W Johnson, N Y Lukomskaya, N N Potapyeva, V E Gmiro and L G Magazanik
      Molecular Pharmacology March 1995, 47 (3) 558-567;

R

  1. Reisz-Porszasz, S

    1. Orientation of the heterodimeric aryl hydrocarbon (dioxin) receptor complex on its asymmetric DNA recognition sequence.
      S G Bacsi, S Reisz-Porszasz and O Hankinson
      Molecular Pharmacology March 1995, 47 (3) 432-438;

  2. Roseboom, P H

    1. Norepinephrine stimulation of pineal cyclic AMP response element-binding protein phosphorylation: primary role of a beta-adrenergic receptor/cyclic AMP mechanism.
      P H Roseboom and D C Klein
      Molecular Pharmacology March 1995, 47 (3) 439-449;

  3. Roth, B L

    1. Differential ergoline and ergopeptine binding to 5-hydroxytryptamine2A receptors: ergolines require an aromatic residue at position 340 for high affinity binding.
      M S Choudhary, N Sachs, A Uluer, R A Glennon, R B Westkaemper and B L Roth
      Molecular Pharmacology March 1995, 47 (3) 450-457;

  4. Rudnick, G

    1. Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: amphetamine specificity for inhibition and efflux.
      S C Wall, H Gu and G Rudnick
      Molecular Pharmacology March 1995, 47 (3) 544-550;

S

  1. Sachs, N

    1. Differential ergoline and ergopeptine binding to 5-hydroxytryptamine2A receptors: ergolines require an aromatic residue at position 340 for high affinity binding.
      M S Choudhary, N Sachs, A Uluer, R A Glennon, R B Westkaemper and B L Roth
      Molecular Pharmacology March 1995, 47 (3) 450-457;

  2. Sands, H

    1. Biodistribution and metabolism of internally 3H-labeled oligonucleotides. II. 3',5'-blocked oligonucleotides.
      H Sands, L J Gorey-Feret, S P Ho, Y Bao, A J Cocuzza, D Chidester and F W Hobbs
      Molecular Pharmacology March 1995, 47 (3) 636-646;

  3. Schambye, H T

    1. Interaction between the nonpeptide angiotensin antagonist SKF-108,566 and histidine 256 (HisVI:16) of the angiotensin type 1 receptor.
      H T Schambye, S A Hjorth, J Weinstock and T W Schwartz
      Molecular Pharmacology March 1995, 47 (3) 425-431;

  4. Schwartz, T W

    1. Interaction between the nonpeptide angiotensin antagonist SKF-108,566 and histidine 256 (HisVI:16) of the angiotensin type 1 receptor.
      H T Schambye, S A Hjorth, J Weinstock and T W Schwartz
      Molecular Pharmacology March 1995, 47 (3) 425-431;

  5. Sciorati, C

    1. Nitric oxide modulation of agonist-evoked intracellular Ca2+ release in neurosecretory PC-12 cells: inhibition of phospholipase C activity via cyclic GMP-dependent protein kinase I.
      E Clementi, I Vecchio, C Sciorati and G Nisticò
      Molecular Pharmacology March 1995, 47 (3) 517-524;

  6. Shamovsky, I L

    1. Molecular mechanics explanation for the stereochemical and shape selectivity of B-DNA for "bay-region" carcinogens.
      L Von Szentpaly and I L Shamovsky
      Molecular Pharmacology March 1995, 47 (3) 624-629;

  7. Sharp, G W

    1. Sodium fluoride stimulates exocytosis at a late site of calcium interaction in stimulus-secretion coupling: studies with the RINm5F beta cell line.
      M Komatsu, A M McDermott and G W Sharp
      Molecular Pharmacology March 1995, 47 (3) 496-508;

  8. Siest, G

    1. Stereoselective esterase activity of human serum albumin toward ketoprofen glucuronide.
      N Dubois-Presle, F Lapicque, M H Maurice, S Fournel-Gigleux, J Magdalou, M Abiteboul, G Siest and P Netter
      Molecular Pharmacology March 1995, 47 (3) 647-653;

  9. Smith, J A

    1. Signal transduction pathways for B1 and B2 bradykinin receptors in bovine pulmonary artery endothelial cells.
      J A Smith, C Webb, J Holford and G M Burgess
      Molecular Pharmacology March 1995, 47 (3) 525-534;

  10. Sproviero, E M

    1. Sodium-retaining activity of some natural and synthetic 21-deoxysteroids.
      G Burton, M Galigniana, S De Lavallaz, A L Brachet-Cota, E M Sproviero, A A Ghini, C P Lantos and M C Damasco
      Molecular Pharmacology March 1995, 47 (3) 535-543;

  11. Sreedharan, S P

    1. Molecular cloning and expression of a human secretin receptor.
      D R Patel, Y Kong and S P Sreedharan
      Molecular Pharmacology March 1995, 47 (3) 467-473;

  12. Stein, R B

    1. Nonsteroidal human progesterone receptor modulators from the marine alga Cymopolia barbata.
      C Pathirana, R B Stein, T S Berger, W Fenical, T Ianiro, D E Mais, A Torres and M E Goldman
      Molecular Pharmacology March 1995, 47 (3) 630-635;

T

  1. Ticku, M K

    1. Chronic neurosteroid treatment produces functional heterologous uncoupling at the gamma-aminobutyric acid type A/benzodiazepine receptor complex in mammalian cortical neurons.
      R Yu and M K Ticku
      Molecular Pharmacology March 1995, 47 (3) 603-610;

  2. Torres, A

    1. Nonsteroidal human progesterone receptor modulators from the marine alga Cymopolia barbata.
      C Pathirana, R B Stein, T S Berger, W Fenical, T Ianiro, D E Mais, A Torres and M E Goldman
      Molecular Pharmacology March 1995, 47 (3) 630-635;

U

  1. Uluer, A

    1. Differential ergoline and ergopeptine binding to 5-hydroxytryptamine2A receptors: ergolines require an aromatic residue at position 340 for high affinity binding.
      M S Choudhary, N Sachs, A Uluer, R A Glennon, R B Westkaemper and B L Roth
      Molecular Pharmacology March 1995, 47 (3) 450-457;

V

  1. Vecchio, I

    1. Nitric oxide modulation of agonist-evoked intracellular Ca2+ release in neurosecretory PC-12 cells: inhibition of phospholipase C activity via cyclic GMP-dependent protein kinase I.
      E Clementi, I Vecchio, C Sciorati and G Nisticò
      Molecular Pharmacology March 1995, 47 (3) 517-524;

  2. Von Szentpaly, L

    1. Molecular mechanics explanation for the stereochemical and shape selectivity of B-DNA for "bay-region" carcinogens.
      L Von Szentpaly and I L Shamovsky
      Molecular Pharmacology March 1995, 47 (3) 624-629;

W

  1. Wall, S C

    1. Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: amphetamine specificity for inhibition and efflux.
      S C Wall, H Gu and G Rudnick
      Molecular Pharmacology March 1995, 47 (3) 544-550;

  2. Webb, C

    1. Signal transduction pathways for B1 and B2 bradykinin receptors in bovine pulmonary artery endothelial cells.
      J A Smith, C Webb, J Holford and G M Burgess
      Molecular Pharmacology March 1995, 47 (3) 525-534;

  3. Weber, E

    1. In vitro pharmacology of ACEA-1021 and ACEA-1031: systemically active quinoxalinediones with high affinity and selectivity for N-methyl-D-aspartate receptor glycine sites.
      R M Woodward, J E Huettner, J Guastella, J F Keana and E Weber
      Molecular Pharmacology March 1995, 47 (3) 568-581;

  4. Weinstock, J

    1. Interaction between the nonpeptide angiotensin antagonist SKF-108,566 and histidine 256 (HisVI:16) of the angiotensin type 1 receptor.
      H T Schambye, S A Hjorth, J Weinstock and T W Schwartz
      Molecular Pharmacology March 1995, 47 (3) 425-431;

  5. Weiss, D S

    1. Zinc is a mixed antagonist of homomeric rho 1 gamma-aminobutyric acid-activated channels.
      Y Chang, J Amin and D S Weiss
      Molecular Pharmacology March 1995, 47 (3) 595-602;

  6. Westkaemper, R B

    1. Differential ergoline and ergopeptine binding to 5-hydroxytryptamine2A receptors: ergolines require an aromatic residue at position 340 for high affinity binding.
      M S Choudhary, N Sachs, A Uluer, R A Glennon, R B Westkaemper and B L Roth
      Molecular Pharmacology March 1995, 47 (3) 450-457;

  7. Wilding, T J

    1. Differential antagonism of alpha-amino-3-hydroxy-5-methyl-4- isoxazolepropionic acid-preferring and kainate-preferring receptors by 2,3-benzodiazepines.
      T J Wilding and J E Huettner
      Molecular Pharmacology March 1995, 47 (3) 582-587;

  8. Willars, G B

    1. Heterologous desensitization of both phosphoinositide and Ca2+ signaling in SH-SY5Y neuroblastoma cells: a role for intracellular Ca2+ store depletion?
      G B Willars and S R Nahorski
      Molecular Pharmacology March 1995, 47 (3) 509-516;

  9. Witt-Enderby, P A

    1. Regulation of airway muscarinic cholinergic receptor subtypes by chronic anticholinergic treatment.
      P A Witt-Enderby, H I Yamamura, M Halonen, J Lai, J D Palmer and J W Bloom
      Molecular Pharmacology March 1995, 47 (3) 485-490;

  10. Woodward, R M

    1. In vitro pharmacology of ACEA-1021 and ACEA-1031: systemically active quinoxalinediones with high affinity and selectivity for N-methyl-D-aspartate receptor glycine sites.
      R M Woodward, J E Huettner, J Guastella, J F Keana and E Weber
      Molecular Pharmacology March 1995, 47 (3) 568-581;

Y

  1. Yamamura, H I

    1. Regulation of airway muscarinic cholinergic receptor subtypes by chronic anticholinergic treatment.
      P A Witt-Enderby, H I Yamamura, M Halonen, J Lai, J D Palmer and J W Bloom
      Molecular Pharmacology March 1995, 47 (3) 485-490;

  2. Yu, R

    1. Chronic neurosteroid treatment produces functional heterologous uncoupling at the gamma-aminobutyric acid type A/benzodiazepine receptor complex in mammalian cortical neurons.
      R Yu and M K Ticku
      Molecular Pharmacology March 1995, 47 (3) 603-610;
Back to top

In this issue

Advertisement